(a) (1) Unless specifically excepted or unless listed in another schedule, it is an offense to knowingly produce, manufacture, distribute, sell, offer for sale, or possess any capsule, pill, or other product composed of or containing any amount of any compound, other than bupropion, that is structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:(A) Substitution in the phenyl ring to any extent with alkyl; alkoxy; alkylenedioxy; haloalkyl; or halide substituents, whether or not further substituted in the phenyl ring by one (1) or more other univalent substituents;(B) Substitution at the 3-position with an alkyl substituent; or(C) Substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.(2) Compounds recognized under subdivision (a)(1) include, but are not limited to:(A) 4-Methoxymethcathinone (Methedrone);(B) 3-Methoxymethcathinone (HMMC);(C) 4-Methyl-alpha-pyrrolidinobutyrophenone (MPBP);(D) 4-Ethylmethcathinone (4-EMC);(E) 3,4-Dimethylmethcathinone (3,4-DMMC);(F) [beta]-Keto-Ethylbenzodioxolylbutanamine (Eutylone);(G) 3,4-Methylenedioxy-N-ethylcathinone (Ethylone);(H) Mitragynine and hydroxymitragynine;(I) Desoxypipradol;(J) URB 754; and(K) URB602.(3) [Deleted by 2026 amendment.]
(1) Unless specifically excepted or unless listed in another schedule, it is an offense to knowingly produce, manufacture, distribute, sell, offer for sale, or possess any capsule, pill, or other product composed of or containing any amount of any compound, other than bupropion, that is structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:(A) Substitution in the phenyl ring to any extent with alkyl; alkoxy; alkylenedioxy; haloalkyl; or halide substituents, whether or not further substituted in the phenyl ring by one (1) or more other univalent substituents;(B) Substitution at the 3-position with an alkyl substituent; or(C) Substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.
(A) Substitution in the phenyl ring to any extent with alkyl; alkoxy; alkylenedioxy; haloalkyl; or halide substituents, whether or not further substituted in the phenyl ring by one (1) or more other univalent substituents;
(B) Substitution at the 3-position with an alkyl substituent; or
(C) Substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.
(2) Compounds recognized under subdivision (a)(1) include, but are not limited to:(A) 4-Methoxymethcathinone (Methedrone);(B) 3-Methoxymethcathinone (HMMC);(C) 4-Methyl-alpha-pyrrolidinobutyrophenone (MPBP);(D) 4-Ethylmethcathinone (4-EMC);(E) 3,4-Dimethylmethcathinone (3,4-DMMC);(F) [beta]-Keto-Ethylbenzodioxolylbutanamine (Eutylone);(G) 3,4-Methylenedioxy-N-ethylcathinone (Ethylone);(H) Mitragynine and hydroxymitragynine;(I) Desoxypipradol;(J) URB 754; and(K) URB602.
(A) 4-Methoxymethcathinone (Methedrone);
(B) 3-Methoxymethcathinone (HMMC);
(C) 4-Methyl-alpha-pyrrolidinobutyrophenone (MPBP);
(D) 4-Ethylmethcathinone (4-EMC);
(E) 3,4-Dimethylmethcathinone (3,4-DMMC);
(F) [beta]-Keto-Ethylbenzodioxolylbutanamine (Eutylone);
(G) 3,4-Methylenedioxy-N-ethylcathinone (Ethylone);
(H) Mitragynine and hydroxymitragynine;
(I) Desoxypipradol;
(J) URB 754; and
(K) URB602.
(3) [Deleted by 2026 amendment.]
(b) Subsection (a) shall not apply to drugs or substances lawfully prescribed or to drugs or substances that have been approved by the federal food and drug administration.
(c) A violation of subsection (a) is a Class A misdemeanor.